7Baggers

Global Medical REIT Inc
(NYSE:GMRE) 

GMRE stock logo

Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.

Sector: Real Estate
Industry: REIT-Healthcare Facilities
REIT
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-11-30 2014-08-31 
                                                   
      revenue
    		                                               
      rental revenue
    		38,021,000 38,172,000 37,036,000 37,880,000 34,595,000 34,952,000 34,175,000 34,214,000 35,069,000 32,931,000 35,487,000 36,317,000 36,199,000 36,290,000 35,347,000 33,679,000 31,852,000 30,312,000 29,967,000 28,200,000 27,325,000 24,895,000 25,055,000 22,036,000 21,533,000 20,422,000 18,117,000 16,835,000 15,141,000 13,385,000 13,111,000 12,581,000 10,488,000 9,293,290 7,921,913 6,666,538 4,629,259 3,085,383 1,932,425 1,762,769 1,298,978 656,527 482,131 455,900 454,638 445,174  
      other income
    		43,000 220,000 193,000 89,000 23,000 204,000 89,000 27,000 49,000 30,000 20,000 34,000 31,000 16,000 59,000 18,000 23,000 31,000 16,000 61,000 24,000 34,000 42,000 19,000 116,000 29,000 78,000 45,000 59,000 27,000 8,000 9,000 8,000 9,498 23,134 58,769 29,599 37,579 70,225 7,890 15,081  4,971  7,500 70  
      total revenue
    		38,064,000 38,392,000 37,229,000 37,969,000 34,618,000 35,156,000 34,264,000 34,241,000 35,118,000 32,961,000 35,507,000 36,351,000 36,230,000 36,306,000 35,406,000 33,697,000 31,875,000 30,343,000 29,983,000 28,261,000 27,349,000 24,929,000 25,097,000 22,055,000 21,649,000 20,451,000 18,195,000 16,880,000 15,200,000 14,375,000 14,003,000 13,249,000 11,564,000 9,873,333 8,388,863 7,422,946 4,658,858 3,122,962 2,002,650 1,770,659 1,314,059 656,527 487,102 455,900 462,138 445,244  
      yoy
    		9.95% 9.20% 8.65% 10.89% -1.42% 6.66% -3.50% -5.80% -3.07% -9.21% 0.29% 7.88% 13.66% 19.65% 18.09% 19.23% 16.55% 21.72% 19.47% 28.14% 26.33% 21.90% 37.93% 30.66% 42.43% 42.27% 29.94% 27.41% 31.44% 45.59% 66.92% 78.49% 148.22% 216.15% 318.89% 319.22% 254.54% 375.68% 311.14% 288.39% 184.34% 47.45%      
      qoq
    		-0.85% 3.12% -1.95% 9.68% -1.53% 2.60% 0.07% -2.50% 6.54% -7.17% -2.32% 0.33% -0.21% 2.54% 5.07% 5.72% 5.05% 1.20% 6.09% 3.33% 9.71% -0.67% 13.79% 1.88% 5.86% 12.40% 7.79% 11.05% 5.74% 2.66% 5.69% 14.57% 17.12% 17.70% 13.01% 59.33% 49.18% 55.94% 13.10% 34.75% 100.15% 34.78% 6.84% -1.35% 3.79%   
      expenses
    		                                               
      general and administrative
    		5,089,000 5,493,000 4,860,000 6,025,000 3,620,000 7,707,000 4,381,000 4,589,000 4,446,000 4,220,000 4,367,000 4,462,000 3,804,000 4,051,000 3,961,000 4,336,000 4,197,000 3,934,000 3,852,000 4,285,000 4,383,000 4,426,000 4,027,000 1,643,000 1,839,000 1,608,000 1,681,000 1,640,000 1,606,000 1,368,000 1,395,000 1,768,000 1,005,000 1,070,885 989,526 2,580,874 2,840,807 1,313,007 1,721,676 368,210 888,529 -13,450 377,810 76,474 64,307 153,560  
      operating expenses
    		9,250,000 8,595,000 8,224,000 8,216,000 7,585,000 7,195,000 7,437,000 7,236,000 7,384,000 6,093,000 7,231,000 7,223,000 7,536,000 7,138,000 6,679,000 6,000,000 5,372,000 4,524,000 3,973,000 3,303,000 3,687,000 2,611,000 3,619,000 2,336,000 2,303,000 2,132,000 1,362,000 1,143,000 1,323,000 994,000 941,000 680,000 1,105,000 625,753 464,514             
      depreciation expense
    		11,087,000 11,198,000 11,213,000 11,307,000 10,307,000 10,194,000 9,993,000 10,127,000 10,113,000 10,204,000 10,100,000 10,468,000 10,494,000 10,580,000 10,128,000 9,898,000 9,402,000 9,046,000 8,639,000 8,292,000 7,848,000 7,364,000 6,954,000 6,593,000 5,836,000 5,585,000 5,006,000 4,608,000 3,867,000 3,679,000 3,614,000 3,445,000 2,906,000 2,556,692 2,175,668 1,850,587 1,346,053 806,383 585,449 544,002 398,830 213,180 153,148 141,007 152,336 149,720  
      amortization expense
    		3,740,000 3,718,000 3,795,000 3,984,000 3,520,000 3,445,000 3,649,000 3,866,000 3,971,000 4,041,000 4,095,000 4,337,000 4,395,000 4,513,000 4,287,000 4,138,000 3,777,000 3,607,000 3,303,000 3,135,000 3,005,000 2,774,000 2,563,000 2,348,000 1,921,000 1,812,000 1,500,000 1,255,000 1,002,000 980,000 953,000 926,000 765,000 745,605 523,487 459,308 343,600           
      interest expense
    		7,233,000 8,403,000 8,175,000 8,009,000 7,167,000 7,570,000 7,236,000 6,992,000 6,890,000 6,984,000 7,170,000 8,468,000 8,271,000 8,064,000 6,963,000 5,401,000 4,801,000 4,809,000 4,830,000 5,020,000 5,037,000 5,064,000 4,864,000 4,375,000 4,378,000 4,765,000 4,549,000 4,132,000 4,025,000 4,294,000 4,055,000 3,942,000 2,684,000 2,169,738 2,174,683 1,990,499 1,100,080 695,495 1,051,204 1,262,646 1,129,263 530,277 363,937 280,846 344,042 335,304  
      total expenses
    		36,399,000 37,407,000 36,267,000 37,541,000 32,199,000 36,266,000 32,696,000 32,810,000 32,804,000 31,542,000 32,963,000 34,960,000 34,542,000 34,458,000 32,130,000 29,863,000 27,589,000 25,925,000 24,615,000 24,097,000 24,026,000 22,337,000 34,677,000 20,383,000 18,832,000 17,676,000 15,887,000 14,418,000 13,157,000 12,546,000 12,230,000 11,865,000 9,663,000 8,625,161 7,783,327 8,045,711 7,200,160 5,052,824 3,985,476 2,264,858 3,260,622 1,447,007 984,895 588,327 650,685 728,584  
      income before other income
    		1,665,000 985,000 962,000 428,000 2,419,000                                           
      gain on sale of investment properties
    		 -372,000 294,000 207,000 1,358,000 5,765,000 1,823,000 -3,383,000   2,289,000 12,786,000                                    
      equity loss from unconsolidated joint ventures
    		-11,000                                               
      net income
    		1,654,000 -6,147,000 -5,058,000 585,000 3,737,000 2,939,000 3,391,000 -1,952,000 2,314,000 551,000 4,833,000 14,177,000 2,173,000 1,848,000 10,029,000 3,834,000 4,286,000 5,487,000 5,368,000 4,164,000 3,323,000 2,592,000 -9,580,000 1,672,000 2,817,000 2,775,000 2,308,000 2,462,000 2,043,000 9,504,000 1,773,000 1,384,000 1,901,000 1,248,172 605,536 -622,765 -2,541,302 -1,929,862 -1,982,826 -494,199 -1,946,563 -790,480 -497,793 -132,427 -188,547 -283,340  
      yoy
    		-55.74% -309.15% -249.16% -129.97% 61.50% 433.39% -29.84% -113.77% 6.49% -70.18% -51.81% 269.77% -49.30% -66.32% 86.83% -7.93% 28.98% 111.69% -156.03% 149.04% 17.96% -6.59% -515.08% -32.09% 37.89% -70.80% 30.17% 77.89% 7.47% 661.43% 192.80% -322.23% -174.80% -164.68% -130.54% 26.02% 30.55% 144.14% 298.32% 273.19% 932.40% 178.99%      
      qoq
    		-126.91% 21.53% -964.62% -84.35% 27.15% -13.33% -273.72% -184.36% 319.96% -88.60% -65.91% 552.42% 17.59% -81.57% 161.58% -10.55% -21.89% 2.22% 28.91% 25.31% 28.20% -127.06% -672.97% -40.65% 1.51% 20.23% -6.26% 20.51% -78.50% 436.04% 28.11% -27.20% 52.30% 106.13% -197.23% -75.49% 31.68% -2.67% 301.22% -74.61% 146.25% 58.80% 275.90% -29.76% -33.46%   
      net income margin %
    		4.35% -16.01% -13.59% 1.54% 10.79% 8.36% 9.90% -5.70% 6.59% 1.67% 13.61% 39.00% 6.00% 5.09% 28.33% 11.38% 13.45% 18.08% 17.90% 14.73% 12.15% 10.40% -38.17% 7.58% 13.01% 13.57% 12.68% 14.59% 13.44% 66.11% 12.66% 10.45% 16.44% 12.64% 7.22% -8.39% -54.55% -61.80% -99.01% -27.91% -148.13% -120.40% -102.19% -29.05% -40.80% -63.64%  
      less: preferred stock dividends
    		-2,473,000 -1,914,000 -1,455,000 -1,455,000 -1,455,000 -1,456,000 -1,455,000 -1,455,000 -1,455,000 -1,456,000 -1,455,000 -1,455,000 -1,455,000 -1,456,000 -1,455,000 -1,455,000 -1,455,000 -1,456,000 -1,455,000 -1,455,000 -1,455,000 -1,456,000 -1,455,000 -1,455,000 -1,455,000 -1,456,000 -1,455,000 -1,455,000 -1,455,000 -1,456,000 -1,455,000 -1,455,000 -1,455,000 -1,455,250 -258,750             
      less: net loss attributable to noncontrolling interest
    		70,000 643,000 512,000 70,000  12,500 -145,000 260,000          -228,000 -224,000   -73,000 767,000     -103,000  -1,012,000 -32,000 7,000  14,518 34,482             
      net income attributable to common stockholders
    		-749,000 -7,418,000 -6,001,000 -800,000 2,104,000 1,374,000 1,791,000 -3,147,000 794,000 -840,000 3,138,000 11,820,000 673,000 368,000 8,057,000 2,236,000 2,661,000 3,803,000 3,689,000 2,553,000 1,756,000 1,063,000 -10,268,000 204,000 1,255,000 1,211,000 770,000 904,000 528,000 7,036,000 286,000 -64,000 411,000 -389,860 381,268             
      net income attributable to common stockholders per share – basic and diluted
    		-0.06 -0.56 -0.45 -0.01 0.03 0.02 0.03 -0.05 0.01 -0.01 0.05 0.18 0.01  0.12 0.03 0.04 0.06 0.06 0.04 0.03 0.02 -0.22  0.03 0.03 0.02 0.03 0.02 0.32 0.01  0.02 -0.02 0.02             
      weighted-average shares outstanding – basic and diluted
    		13,235 13,379 13,393 66,879 66,873 65,936 65,737 65,588 65,573 65,550 65,565 65,544 65,525 65,462 65,518 65,507 65,302 60,640 64,204 61,194 52,671 46,256 46,908 45,404 44,182 33,865 35,512 34,559 27,380 21,971 21,797 21,631 21,631 19,617 21,522,251 17,644,137 17,605,675 9,302,244 17,371,743 1,426,656 624,978 250,000 250,000 250,000 250,000 250,000  
      impairment of investment property
    		 -1,570,250 -6,281,000                                             
      equity loss from unconsolidated joint venture
    		 -27,000 -33,000 -50,000 -40,000                                           
      less: net income attributable to noncontrolling interest
    		    -178,000    -65,000 65,000 -240,000 -902,000 -45,000 -207,500 -517,000 -143,000 -170,000   -156,000 -112,000   -13,000 -107,000 -61,500 -83,000  -60,000    -35,000               
      preacquisition expense
    		           2,000 42,000 112,000 112,000 90,000 40,000 5,000 18,000 62,000 66,000 98,000 70,000 147,000                        
      income before gain on sale of investment properties
    		     1,328,250 1,568,000 1,431,000  1,405,750 2,544,000 1,391,000                                    
      income before gain on sale of investment property
    		        2,314,000    1,688,000 1,848,000 3,276,000                                 
      gain on sale of investment property
    		            485,000  6,753,000                                 
      management fees – related party
    		                       2,021,000 2,002,000 1,727,000 1,621,000 1,584,000 1,334,000 1,142,000 1,104,000 1,095,000 1,081,000 1,063,675 803,804 628,374 627,147 627,147 627,147 90,000 90,000       
      management internalization expense
    		                      12,580,000 920,000 504,000                       
      ​
    		                                               
      preacquisition fees
    		                        49,000 47,000 168,000 56,000                    
      acquisition fees
    		                             89,000 168,000 9,000 117,000 392,813 651,645 536,069 942,473           
      expense recoveries
    		                             963,000 884,000 659,000 1,068,000 570,545 443,816 697,639            
      acquisition fees – related party
    		                                        754,000       
      net income per share
    		                                   -0.04 -0.14  -0.11 -0.35 -3.11 -3.16 -1.99 -0.53 -0.75 -1.13  
      management fees
    		                                         67,500 90,000 90,000 90,000 90,000  
      revenue:
    		                                               
      expenses:
    		                                               
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-11-30 2014-08-31 2014-05-31 2014-02-28 2013-11-30 2013-08-31 2012-11-30 2012-08-31 2012-02-29 
                                                            
        assets
      		                                                      
        investment in real estate:
      		                                                      
        land
      		169,917,000 169,917,000 171,349,000 173,123,000 173,293,000 174,300,000 168,110,000 162,391,000 164,315,000 164,315,000 164,315,000 165,242,000 167,285,000 168,308,000 168,289,000 165,045,000 155,529,000 152,060,000 149,249,000 145,424,000 133,040,000 128,857,000 116,123,000 104,316,000 101,715,000 95,381,000 86,878,000 76,831,000 68,326,000 63,710,000 56,839,000 55,330,000 52,301,000 42,701,000 36,839,127 25,822,453 23,130,337 17,785,001 11,733,852 7,043,852 7,043,852 4,563,852 1,859,400 572,400           
        building
      		1,073,953,000 1,072,124,000 1,087,622,000 1,095,324,000 1,064,782,000 1,044,019,000 1,041,006,000 1,028,539,000 1,036,224,000 1,035,705,000 1,034,822,000 1,038,464,000 1,077,340,000 1,079,781,000 1,079,380,000 1,049,876,000 1,002,087,000 985,091,000 964,169,000 931,510,000 883,901,000 851,427,000 793,559,000 755,807,000 745,649,000 693,533,000 637,505,000 597,029,000 533,430,000 518,451,000 493,503,000 486,766,000 436,185,000 384,338,000 349,041,480 306,198,609 270,401,823 179,253,398                 
        site improvements
      		25,783,000 25,741,000 25,065,000 24,966,000 24,266,000 23,973,000 22,946,000 21,960,000 21,984,000 21,974,000 21,480,000 21,404,000 22,024,000 22,024,000 21,983,000 20,805,000 19,596,000 19,021,000 18,017,000 17,011,000 15,669,000 15,183,000 13,268,000 11,593,000 11,303,000 9,912,000 9,100,000 7,672,000 6,982,000 6,880,000 6,714,000 6,562,000 5,590,000 4,808,000 3,992,974 3,115,289 2,686,216 1,465,273                 
        tenant improvements
      		81,168,000 80,397,000 79,979,000 80,019,000 75,023,000 69,679,000 66,933,000 66,004,000 67,021,000 66,358,000 65,772,000 66,544,000 66,375,000 65,987,000 65,004,000 62,500,000 60,154,000 58,900,000 56,156,000 53,730,000 50,596,000 49,204,000 46,965,000 41,891,000 37,044,000 33,909,000 31,465,000 27,371,000 16,206,000 15,357,000 14,328,000 12,189,000 9,201,000 8,010,000 5,095,651 2,996,662 2,552,449 1,186,014                 
        acquired lease intangible assets
      		144,573,000 144,573,000 144,696,000 147,376,000 141,828,000 138,945,000 137,886,000 136,394,000 138,617,000 138,617,000 138,617,000 139,715,000 148,249,000 148,077,000 147,836,000 146,339,000 130,790,000 127,931,000 123,918,000 112,649,000 103,269,000 98,234,000 91,465,000 83,269,000 78,977,000 72,794,000 65,498,000 54,698,000 43,987,000 43,152,000 41,653,000 41,162,000 34,034,000 31,650,000 27,308,632 17,218,214 15,991,981 7,144,276                 
        investment in real estate: - sum
      		1,495,394,000 1,492,752,000 1,508,711,000 1,520,808,000 1,479,192,000 1,450,916,000 1,436,881,000 1,415,288,000 1,428,161,000 1,426,969,000 1,425,006,000 1,431,369,000 1,481,273,000 1,484,177,000 1,482,492,000 1,444,565,000 1,368,156,000 1,343,003,000 1,311,509,000 1,260,324,000 1,186,475,000 1,142,905,000                                 
        less: accumulated depreciation and amortization
      		-353,309,000 -338,096,000 -327,248,000 -316,649,000 -301,190,000 -288,921,000 -283,941,000 -271,764,000 -262,287,000 -247,503,000 -232,518,000 -218,109,000 -213,690,000 -198,218,000 -182,255,000 -172,006,000 -157,132,000 -143,255,000 -130,284,000 -117,720,000 -105,779,000 -94,462,000 -83,893,000 -73,979,000 -64,635,000 -56,503,000 -48,731,000 -41,882,000 -35,771,000 -30,625,000 -26,839,000 -22,026,000 -17,420,000 -13,594,000 -10,142,823                    
        investment in real estate
      		1,142,085,000 1,154,656,000 1,181,463,000 1,204,159,000 1,178,002,000 1,161,995,000 1,152,940,000 1,143,524,000 1,165,874,000 1,179,466,000 1,192,488,000 1,213,260,000 1,267,583,000 1,285,959,000 1,300,237,000 1,272,559,000 1,211,024,000 1,199,748,000 1,181,225,000 1,142,604,000 1,080,696,000 1,048,443,000 977,487,000 922,897,000 910,053,000 849,026,000 781,715,000 721,719,000 633,160,000 616,925,000 586,198,000 579,983,000 519,891,000 457,913,000 412,135,041 331,612,458 294,100,857 196,365,771 122,311,086 92,152,179 92,696,181 55,148,872 35,206,363 23,750,839 23,891,846 24,094,961 21,737,984        
        cash and cash equivalents
      		8,183,000 9,084,000 7,123,000 6,580,000 5,412,000 6,815,000 5,723,000 4,978,000 1,333,000 1,278,000 1,281,000 2,460,000 4,603,000 4,016,000 3,199,000 5,873,000 1,854,000 7,213,000 6,030,000 5,821,000 5,304,000 5,507,000 2,052,000 8,392,000 11,340,000 2,765,000 2,815,000 3,216,000 1,844,000 3,631,000 3,005,000 4,755,000 3,351,000 5,109,000 6,776,501 12,033,797 8,356,599 19,671,131 81,347,992 2,574,804 507,281 9,184,270 300,579 341,422 369,105 332,576 162,985  3,415 3,466 3,519 11,193 12,313 47,189 
        restricted cash
      		2,778,000 2,805,000 2,717,000 2,646,000 2,176,000 2,127,000 2,066,000 2,840,000 6,473,000 5,446,000 6,331,000 7,325,000 9,378,000 10,439,000 10,396,000 8,327,000 6,336,000 5,546,000 5,839,000 6,549,000 6,096,000 5,246,000 5,210,000 4,945,000 5,536,000 4,420,000 3,011,000 2,656,000 1,464,000 1,212,000 817,000 1,432,000 4,050,000 2,005,000 2,040,026 2,291,080 1,773,909 941,344 805,776 977,578 1,277,831 447,627             
        tenant receivables
      		6,800,000 7,225,000 7,945,000 7,826,000 8,104,000 7,424,000 8,122,000 8,073,000 7,743,000 6,762,000 7,527,000 7,381,000 7,402,000 8,040,000 6,382,000 6,189,000 6,477,000 6,070,000 5,126,000 4,886,000 5,585,000 5,596,000 6,702,000 5,888,000 5,708,000 4,957,000 4,167,000 3,935,000 3,559,000 2,905,000 1,744,000 1,339,000 1,253,000 704,000 616,741 534,484 347,110 212,435 177,369  261,955  25,058            
        due from related parties
      		177,000 162,000 367,000 461,000 420,000 270,000 404,000 410,000 363,000 193,000 289,000 391,000 321,000 200,000 337,000 337,000 451,000 163,000 275,000 265,000 229,000 103,000 121,000 124,000 70,000 50,000 75,000                            
        escrow deposits
      		546,000 556,000 552,000 556,000 915,000 711,000 1,694,000 925,000 737,000 673,000 9,861,000 9,725,000 8,625,000 7,833,000 7,660,000 7,708,000 7,697,000 5,957,000 5,970,000 5,531,000 5,163,000 4,817,000 3,792,000 3,301,000 3,589,000 3,417,000 2,865,000 3,518,000 3,296,000 1,752,000 2,628,000 2,080,000 2,508,000 1,638,000 1,297,665 979,709 2,528,996 1,212,177 903,636 945,162 889,519 454,310    14,940 14,940 7,775,082       
        deferred assets
      		29,953,000 28,907,000 29,205,000 28,672,000 28,251,000 28,208,000 27,685,000 28,360,000 27,995,000 27,132,000 26,748,000 26,189,000 30,322,000 29,616,000 28,667,000 27,731,000 26,714,000 25,417,000 24,422,000 23,050,000 21,676,000 20,272,000 18,928,000 17,433,000 16,141,000 14,512,000 13,307,000 11,831,000 10,358,000 9,352,000 8,590,000 7,200,000 5,171,000 3,993,000 2,923,494 1,867,010 1,087,148 704,537 245,619 1,735,973 436,068 93,646             
        derivative assets
      		7,218,000 6,102,000                                                     
        goodwill
      		5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000                                
        investment in unconsolidated joint ventures
      		8,902,000                                                      
        other assets
      		25,474,000 25,284,000 28,650,000 27,843,000 24,667,000 22,354,000 23,091,000 18,530,000 17,874,000 15,722,000 13,713,000 12,302,000 7,473,000 6,550,000 7,042,000 6,056,000 6,345,000 6,232,000 8,297,000 5,219,000 5,530,000 5,019,000 5,356,000 3,587,000 3,731,000 3,593,000 4,363,000 3,847,000 3,009,000 322,000 1,109,000 2,283,000 527,000 459,000 160,214 88,695 11,484 140,374                 
        total assets
      		1,238,019,000 1,242,465,000 1,273,238,000 1,296,959,000 1,269,555,000 1,256,486,000 1,242,595,000 1,241,215,000 1,263,580,000 1,267,700,000 1,302,520,000 1,320,800,000 1,369,038,000 1,393,261,000 1,406,749,000 1,357,266,000 1,285,493,000 1,263,485,000 1,243,306,000 1,199,965,000 1,136,318,000 1,100,906,000 1,025,551,000 966,567,000 956,168,000 884,934,000 812,318,000 750,722,000 656,690,000 636,099,000 604,091,000 602,027,000 539,856,000 474,571,000 428,927,663 369,395,591 325,768,465 227,319,130 205,791,478 98,385,696 96,096,760 65,328,725 35,872,802 24,349,378 24,523,248 24,746,893 22,244,759 7,775,082       
        liabilities and equity
      		                                                      
        liabilities:
      		                                                      
        credit facility, net of unamortized debt issuance costs of 9,686 and 10,476 at march 31, 2026 and december 31, 2025, respectively
      		662,314,000                                                      
        notes payable, net of unamortized debt issuance costs of 0 at march 31, 2026 and december 31, 2025
      		1,096,000                                                      
        accounts payable and accrued expenses
      		15,022,000 18,289,000 17,808,000 19,006,000 14,519,000 16,468,000 13,350,000 11,962,000 10,520,000 12,781,000 13,300,000 15,457,000 12,604,000 13,819,000 13,100,000 11,922,000 9,272,000 10,344,000 11,065,000 8,080,000 7,230,000 7,279,000 8,329,000 8,836,000 7,144,000 5,069,000 5,501,000 4,224,000 3,385,000 3,664,000 4,420,000 5,494,000 4,125,000 2,020,000 2,433,549 2,216,953 1,932,590 573,997     315,816 138,227 113,361          
        dividends payable
      		12,708,000 12,484,000 12,051,000 11,985,000 16,597,000 16,520,000 16,534,000 16,280,000 16,157,000 16,134,000 16,055,000 16,048,000 15,854,000 15,821,000 15,777,000 15,926,000 15,823,000 15,668,000 15,309,000 15,251,000 14,482,000 12,470,000 11,843,000 11,281,000 10,949,000 11,091,000 9,470,000 9,081,000 8,985,000 6,981,000 6,109,000 5,940,000 5,826,000 5,638,000 4,767,037 3,700,936 3,651,817 3,604,037 3,592,786       21,300         
        security deposits
      		3,486,000 3,421,000 3,512,000 3,407,000 3,374,000 3,324,000 3,222,000 3,973,000 4,376,000 3,688,000 3,913,000 4,213,000 4,688,000 5,461,000 5,404,000 5,304,000 4,616,000 4,540,000 4,600,000 4,385,000 4,367,000                2,099,844 719,592 597,593 319,499 319,499              
        other liabilities
      		18,368,000 19,410,000 18,888,000 18,438,000 16,030,000 14,191,000 12,370,000 12,809,000 12,952,000 12,770,000 12,138,000 12,137,000 8,226,000 7,363,000 6,848,000 7,428,000 7,090,000 7,709,000 7,104,000 5,983,000 6,793,000 6,171,000                                 
        acquired lease intangible liabilities
      		4,375,000 4,944,000                                                     
        total liabilities
      		717,369,000 712,400,000 767,410,000 771,938,000 731,452,000 700,570,000 677,989,000 662,843,000 666,482,000 661,886,000 668,872,000 679,408,000 740,563,000 744,196,000 742,165,000 708,157,000 632,876,000 625,908,000 613,081,000 562,710,000 540,499,000 643,146,000 576,344,000 523,858,000 517,378,000 424,581,000 440,875,000 389,119,000 286,128,000 336,349,000 349,435,000 346,514,000 285,113,000 215,558,000 175,900,856 193,092,997 176,513,596 72,290,752 46,083,186 86,250,769 83,346,083 65,467,333 35,157,030 23,071,913 23,049,456 22,872,824 20,023,450 7,819,244       
        commitments and contingencies
      		                                                      
        equity:
      		                                                      
        preferred stock, 0.001 par value...
      		124,106,000 124,106,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,000 74,959,003                    
        common stock, 0.001 par value...
      		13,000 13,000 13,000 67,000 67,000 67,000 67,000 66,000 66,000 66,000 66,000 66,000 66,000 66,000 66,000 66,000 65,000 65,000 64,000 64,000 61,000 49,000 48,000 46,000 44,000 44,000 36,000 35,000 35,000 26,000 22,000 22,000 22,000 22,000 21,631                    
        additional paid-in capital
      		729,514,000 729,514,000 735,416,000 734,290,000 734,290,000 734,223,000 733,626,000 722,627,000 722,623,000 722,418,000 722,418,000 722,418,000 722,113,000 721,991,000 722,074,000 722,074,000 720,306,000 711,414,000 700,206,000 700,038,000 648,949,000 504,789,000 487,114,000 462,607,000 440,220,000 433,330,000 340,435,000 322,872,000 322,359,000 243,038,000 208,938,000 205,788,000 205,788,000 205,788,000 207,268,720 202,513,240 172,417,006 171,997,396 171,143,411 18,010,613 18,010,613 3,011,790 3,011,790 3,011,790 3,011,790 3,011,790 3,011,790 72,000 72,000 72,000 72,000 72,000 49,500 49,500 
        accumulated deficit
      		-360,640,000 -349,965,000 -332,566,000 -316,510,000 -305,677,000 -293,736,000 -281,067,000 -268,885,000 -251,963,000 -238,984,000 -224,375,000 -213,744,000 -211,794,000 -198,706,000 -185,316,000 -179,614,000 -168,089,000 -157,017,000 -147,562,000 -138,088,000 -127,480,000 -116,773,000 -107,943,000 -88,037,000 -78,990,000 -71,389,000 -63,846,000 -57,397,000 -51,390,000 -45,007,000 -46,855,000 -42,739,000 -38,349,000 -34,434,000 -29,914,472 -26,231,752 -23,179,743 -16,986,624 -11,452,725 -5,877,113 -5,261,363 -3,150,648 -2,296,268 -1,734,575 -1,538,248 -1,137,971 -790,731 -124,162       
        accumulated other comprehensive income
      		7,218,000 6,102,000 7,467,000 10,396,000 13,713,000 18,613,000 14,967,000 27,672,000 29,285,000 25,125,000 38,379,000 35,859,000 27,410,000 34,674,000 36,883,000 16,527,000 10,757,000                                      
        total chiron real estate inc. stockholders' equity
      		500,211,000                                                      
        noncontrolling interest
      		20,439,000 20,295,000 20,539,000 21,819,000 20,751,000 21,790,000 22,054,000 21,933,000 22,128,000 22,230,000 22,201,000 21,834,000 15,721,000 16,081,000 15,918,000 15,097,000 14,619,000 14,792,000 14,504,000 14,066,000 13,918,000 12,955,000 14,680,000 14,788,000 23,189,000 30,083,000 30,455,000 30,427,000 30,342,000 30,455,000 17,701,000 17,483,000 12,323,000 12,678,000 691,925                    
        total equity
      		520,650,000 530,065,000 505,828,000 525,021,000 538,103,000 555,916,000 564,606,000 578,372,000 597,098,000 605,814,000 633,648,000 641,392,000 628,475,000 649,065,000 664,584,000 649,109,000 652,617,000 637,577,000 630,225,000 637,255,000 595,819,000 457,760,000 449,207,000 442,709,000 438,790,000 460,353,000 371,443,000 361,603,000      259,013,000 253,026,807                    
        total liabilities and equity
      		1,238,019,000 1,242,465,000 1,273,238,000 1,296,959,000 1,269,555,000 1,256,486,000 1,242,595,000 1,241,215,000 1,263,580,000 1,267,700,000 1,302,520,000 1,320,800,000 1,369,038,000 1,393,261,000 1,406,749,000 1,357,266,000 1,285,493,000 1,263,485,000 1,243,306,000 1,199,965,000 1,136,318,000 1,100,906,000 1,025,551,000 966,567,000 956,168,000 884,934,000 812,318,000 750,722,000                           
        investment in unconsolidated joint venture
      		 1,781,000 1,846,000 1,917,000 1,992,000 2,066,000                                                 
        credit facility, net of unamortized debt issuance costs of 10,476 and 4,868 at december 31, 2025, and december 31, 2024, respectively
      		 652,699,000                                                     
        notes payable, net of unamortized debt issuance costs of 0 and 22 at december 31, 2025, and december 31, 2024, respectively
      		 1,153,000                                                     
        total chiron real estate stockholders' equity
      		 509,770,000                                                     
        derivative asset
      		  7,467,000 10,396,000 13,713,000 18,613,000 14,967,000 27,672,000 29,285,000 25,125,000 38,379,000 35,864,000 27,428,000 34,705,000 36,926,000 16,583,000 12,692,000 1,236,000 219,000 137,000 136,000     2,194,000                             
        credit facility, net of unamortized debt issuance costs of 3,218 and 4,868 at september 30, 2025 and december 31, 2024, respectively
      		  708,482,000                                                    
        notes payable, net of unamortized debt issuance costs of 22 at december 31, 2024
      		  1,153,000                                                    
        acquired lease intangible liability
      		  5,516,000 6,117,000 3,902,000 3,936,000 3,638,000 4,149,000 4,713,000 5,281,000 5,860,000 6,444,000 7,028,000 7,613,000 8,220,000 7,903,000 8,161,000 8,128,000 8,333,000 8,437,000 7,998,000 8,222,000 8,621,000 5,598,000 3,425,000 3,164,000 3,287,000 2,778,000 2,004,000 2,028,000 2,034,000 2,081,000 1,488,000 1,291,000 1,080,123 1,112,566 475,343 277,917                 
        total global medical reit inc. stockholders' equity
      		  485,289,000 503,202,000 517,352,000 534,126,000 542,552,000 556,439,000 574,970,000 583,584,000 611,447,000 619,558,000 612,754,000 632,984,000 648,666,000 634,012,000 637,998,000 622,785,000 615,721,000 623,189,000 581,901,000 444,805,000 434,527,000  415,601,000 430,270,000 340,988,000 331,176,000  269,295,000 236,955,000 238,030,000 242,420,000 246,335,000 252,334,882                    
        credit facility, net of unamortized debt issuance costs of 3,768 and 4,868 at june 30, 2025 and december 31, 2024, respectively
      		   698,832,000                                                   
        notes payable, net of unamortized debt issuance costs of 4 and 22 at june 30, 2025 and december 31, 2024, respectively
      		   14,153,000                                                   
        credit facility, net of unamortized debt issuance costs of 4,318 and 4,868 at march 31, 2025 and december 31, 2024, respectively
      		    662,782,000                                                  
        notes payable, net of unamortized debt issuance costs of 13 and 22 at march 31, 2025 and december 31, 2024, respectively
      		    14,248,000                                                  
        credit facility, net of unamortized debt issuance costs of 4,868 and 7,067 at december 31, 2024 and december 31, 2023, respectively
      		     631,732,000                                                 
        notes payable, net of unamortized debt issuance costs of 22 and 66 at december 31, 2024 and december 31, 2023, respectively
      		     14,399,000                                                 
        credit facility, net of unamortized debt issuance costs of 5,418 and 7,067 at september 30, 2024 and december 31, 2023, respectively
      		      614,382,000                                                
        notes payable, net of unamortized debt issuance costs of 31 and 66 at september 30, 2024 and december 31, 2023, respectively
      		      14,493,000                                                
        credit facility, net of unamortized debt issuance costs of 5,968 and 7,067 at june 30, 2024 and december 31, 2023, respectively
      		       599,032,000                                               
        notes payable, net of unamortized debt issuance costs of 40 and 66 at june 30, 2024 and december 31, 2023, respectively
      		       14,638,000                                               
        credit facility, net of unamortized debt issuance costs of 6,518 and 7,067 at march 31, 2024 and december 31, 2023, respectively
      		        592,082,000                                              
        notes payable, net of unamortized debt issuance costs of 53 and 66 at march 31, 2024 and december 31, 2023, respectively
      		        25,682,000                                              
        credit facility, net of unamortized debt issuance costs of 7,067 and 9,253 at december 31, 2023 and december 31, 2022, respectively
      		         585,333,000                                             
        notes payable, net of unamortized debt issuance costs of 66 and 452 at december 31, 2023 and december 31, 2022, respectively
      		         25,899,000                                             
        credit facility, net of unamortized debt issuance costs of 7,617 and 9,253 at september 30, 2023 and december 31, 2022, respectively
      		          560,783,000                                            
        notes payable, net of unamortized debt issuance costs of 337 and 452 at september 30, 2023 and december 31, 2022, respectively
      		          56,823,000                                            
        credit facility, net of unamortized debt issuance costs of 8,155 and 9,253 at june 30, 2023 and december 31, 2022, respectively
      		           567,988,000                                           
        notes payable, net of unamortized debt issuance costs of 375 and 452 at june 30, 2023 and december 31, 2022, respectively
      		           57,121,000                                           
        credit facility, net of unamortized debt issuance costs of 8,704 and 9,253 at march 31, 2023 and december 31, 2022, respectively
      		            634,796,000                                          
        notes payable, net of unamortized debt issuance costs of 413 and 452 at march 31, 2023 and december 31, 2022, respectively
      		            57,367,000                                          
        credit facility, net of unamortized debt issuance costs of 9,253 and 8,033 at december 31, 2022 and december 31, 2021, respectively
      		             636,447,000                                         
        notes payable, net of unamortized debt issuance costs of 452 and 607 at december 31, 2022 and december 31, 2021, respectively
      		             57,672,000                                         
        derivative liability
      		                1,865,000 7,790,000 12,070,000 13,814,000 14,603,000 18,086,000 19,505,000 21,495,000 20,461,000 8,685,000 10,399,000 9,083,000 5,520,000 3,487,000                         
        credit facility, net of unamortized debt issuance costs of 9,802 and 8,033 at september 30, 2022 and december 31, 2021, respectively
      		              634,898,000                                        
        notes payable, net of unamortized debt issuance costs of 491 and 607 at september 30, 2022 and december 31, 2021, respectively
      		              57,918,000                                        
        credit facility, net of unamortized debt issuance costs of 7,113 and 8,033 at june 30, 2022 and december 31, 2021, respectively
      		               602,987,000                                       
        notes payable, net of unamortized debt issuance costs of 530 and 607 at june 30, 2022 and december 31, 2021, respectively
      		               56,687,000                                       
        credit facility, net of unamortized debt issuance costs of 7,570 and 8,033 at march 31, 2022 and december 31, 2021, respectively
      		                529,130,000                                      
        notes payable, net of unamortized debt issuance costs of 568 and 607 at march 31, 2022 and december 31, 2021, respectively
      		                56,919,000                                      
        credit facility, net of unamortized debt issuance costs of 8,033 and 3,559 at december 31, 2021 and december 31, 2020, respectively
      		                 514,567,000                                     
        notes payable, net of unamortized debt issuance costs of 607 and 835 at december 31, 2021 and december 31, 2020, respectively
      		                 57,162,000                                     
        accumulated other comprehensive loss
      		                 -6,636,000 -11,946,000 -13,784,000 -14,588,000 -18,219,000 -19,651,000 -21,654,000 -20,632,000 -6,674,000 -10,596,000 -9,293,000 -5,743,000 -3,721,000 -109,000                        
        credit facility, net of unamortized debt issuance costs of 8,497 and 3,559 at september 30, 2021 and december 31, 2020, respectively
      		                  497,203,000                                    
        notes payable, net of unamortized debt issuance costs of 644 and 835 at september 30, 2021 and december 31, 2020, respectively
      		                  57,397,000                                    
        credit facility, net of unamortized debt issuance costs of 8,960 and 3,559 at june 30, 2021 and december 31, 2020, respectively
      		                   442,140,000                                   
        notes payable, net of unamortized debt issuance costs of 706 and 835 at june 30, 2021 and december 31, 2020, respectively
      		                   64,620,000                                   
        credit facility, net of unamortized debt issuance costs of 3,284 and 3,559 at march 31, 2021 and december 31, 2020, respectively
      		                    420,216,000                                  
        notes payable, net of unamortized debt issuance costs of 772 and 835 at march 31, 2021 and december 31, 2020, respectively
      		                    64,810,000                                  
        credit facility, net of unamortized debt issuance costs of 3,559 and 3,832 at december 31, 2020 and december 31, 2019, respectively
      		                     521,641,000                                 
        notes payable, net of unamortized debt issuance costs of 835 and 667 at december 31, 2020 and december 31, 2019, respectively
      		                     64,937,000                                 
        security deposits and other
      		                     4,340,000 5,571,000 5,814,000 6,546,000 6,351,000 6,362,000 5,881,000 4,122,000 4,152,000 3,928,000 5,052,000 4,912,000 2,128,000 2,206,145 2,444,842                   
        due to related party
      		                       1,957,000 1,948,000 1,648,000                847,169  506,718 420,768 300,768         
        ​
      		                      1,061,380,000 996,876,000                               
        credit facility, net of unamortized debt issuance costs of 3,875 and 3,832 at september 30, 2020 and december 31, 2019, respectively
      		                      454,325,000                                
        notes payable, net of unamortized debt issuance costs of 898 and 667 at september 30, 2020 and december 31, 2019, respectively
      		                      65,060,000                                
        other liability
      		                      3,090,000 2,417,000 2,414,000 2,405,000 2,379,000 2,371,000 2,367,000                          
        credit facility, net of unamortized debt issuance costs of 3,350 and 3,832 at june 30,2020 and december 31, 2019, respectively
      		                       415,850,000                               
        notes payable, net of unamortized debt issuance costs of 668 and 667 at june 30,2020 and december 31, 2019, respectively
      		                       50,610,000                               
        total global medical reit inc. stockholders’ equity
      		                       427,921,000     340,220,000                          
        credit facility, net of unamortized debt issuance costs of 3,607 and 3,832 at march 31, 2020 and december 31, 2019, respectively
      		                        425,843,000                              
        notes payable, net of unamortized debt issuance costs of 634 and 667 at march 31, 2020 and december 31, 2019, respectively
      		                        38,648,000                              
        credit facility, net of unamortized debt issuance costs of 3,832 and 3,922 at december 31, 2019 and 2018, respectively
      		                         347,518,000                             
        notes payable, net of unamortized debt issuance costs of 667 and 799 at december 31, 2019 and 2018, respectively
      		                         38,650,000                             
        credit facility, net of unamortized discount of 3,983 and 3,922 at september 30, 2019 and december 31, 2018, respectively
      		                          363,242,000                            
        notes payable, net of unamortized discount of 701 and 799 at september 30, 2019 and december 31, 2018, respectively
      		                          38,651,000                            
        due to related parties
      		                          1,584,000 1,358,000 1,100,000 1,030,000 1,028,000 987,000 1,035,000 1,036,000 802,286 638,790 586,899 580,911 1,135,302 2,493,401 1,068,562  580,283    213,000  23,315 5,894 380 380 380 380 
        credit facility, net of unamortized discount of 3,784 and 3,922 at june 30, 2019 and december 31, 2018, respectively
      		                           315,691,000                           
        notes payable, net of unamortized discount of 733 and 799 at june 30, 2019 and december 31, 2018, respectively
      		                           38,652,000                           
        liabilities and stockholders’ equity
      		                                                      
        credit facility, net of unamortized discount of 3,682 and 3,922 at march 31, 2019 and december 31, 2018, respectively
      		                            219,993,000                          
        notes payable, net of unamortized discount of 766 and 799 at march 31, 2019 and december 31, 2018, respectively
      		                            38,652,000                          
        stockholders’ equity:
      		                                                      
        total stockholders’ equity
      		                            370,562,000 299,750,000 254,656,000 255,513,000 254,743,000               -44,162 -37,257 -23,570 -15,905 1,813 4,433 46,809 
        total liabilities and stockholders’ equity
      		                            656,690,000                   7,775,082 7,047 3,466 3,519 11,193 12,313 47,189 
        -3-
      		                                                      
        revolving credit facility, net of unamortized discount of 3,922 and 2,750 at december 31, 2018 and 2017, respectively
      		                             276,353,000                         
        notes payable, net of unamortized discount of 799 and 930 at december 31, 2018 and 2017, respectively
      		                             38,654,000                         
        stockholders' equity:
      		                                                      
        total liabilities and stockholders' equity
      		                             636,099,000 604,091,000 602,027,000 539,856,000 474,571,000 428,927,663 369,395,591 325,768,465 227,319,130 205,791,478 98,385,696 96,096,760              
        revolving credit facility, net of unamortized discount of 4,127 and 2,750 at september 30, 2018 and december 31, 2017, respectively
      		                              293,273,000                        
        notes payable, net of unamortized discount of 832 and 930 at september 30, 2018 and december 31, 2017, respectively
      		                              38,643,000                        
        deferred financing costs
      		                               2,955,000 3,105,000 2,750,000 2,977,981 2,770,144 1,570,381 927,085     339,576 232,098 261,894 301,623 309,543        
        revolving credit facility
      		                               288,350,000 229,150,000 164,900,000 126,100,000 144,500,000 128,900,000 27,700,000                 
        notes payable, net of unamortized discount of 865 and 930 at june 30, 2018 and december 31, 2017, respectively
      		                               38,610,000                       
        notes payable, net of unamortized discount of 898 and 930 at march 31, 2018 and december 31, 2017, respectively
      		                                38,577,000                      
        notes payable, net of unamortized discount of 930 and 1,062 at december 31, 2017 and 2016, respectively
      		                                 38,545,000                     
        notes payable to related parties
      		                                    421,000 421,000 421,000                
        notes payable, net of unamortized discount of 963,184 and 1,061,602 at september 30, 2017 and december 31, 2016, respectively
      		                                  38,511,716                    
        less: accumulated depreciation
      		                                   -6,520,555 -4,669,968 -3,323,915 -2,517,532 -1,932,083 -1,388,081 -989,251 -776,071 -622,923 -481,916 -278,801 -129,081        
        notes payable, net of unamortized discount of 995,990 and 1,061,602 at june 30, 2017 and december 31, 2016, respectively
      		                                   38,478,910                   
        common stock 0.001 par value...
      		                                   21,106 17,606 17,606 17,606 1,427 1,427 250 250 250 250 250 250        
        total stockholders' equity
      		                                   176,302,594 149,254,869 155,028,378 159,708,292 12,134,927 12,750,677              
        notes payable, net of unamortized discount of 1,028,797 and 1,061,602 at march 31, 2017 and december 31, 2016, respectively
      		                                    38,446,103                  
        convertible debenture, due to related party
      		                                              4,536,102        
        notes payable, net of unamortized discount of 1,061,602 and 302,892 at december 31, 2016 and december 31, 2015, respectively
      		                                     38,413,298                 
        stockholders' equity
      		                                                      
        building and improvements
      		                                      113,094,766 87,040,410 87,040,410 51,574,271 34,123,034 23,801,362 24,373,762 24,373,762 21,867,065        
        accrued expenses
      		                                      416,230 3,078,078 1,568,004 683,857    306,459         
        notes payable, net of unamortized discount of 1,177,522 and 302,892 at september 30, 2016 and december 31, 2015, respectively
      		                                      39,920,275                
        convertible debenture, due to majority stockholder
      		                                       25,030,134 25,030,134 40,030,134             
        note payable to majority stockholder
      		                                       421,000 421,000 421,000             
        note payable to related party
      		                                       450,000 450,000              
        notes payable, net of unamortized discount of 1,240,126 and 302,892 at june 30, 2016 and december 31, 2015, respectively
      		                                       54,458,657               
        prepaid assets
      		                                        27,925              
        notes payable, net of unamortized discount of 1,302,730 and 302,892, respectively
      		                                        54,488,884              
        accounts receivable
      		                                            403 2,793         
        liabilities and stockholders’ (deficit) equity
      		                                                      
        notes payable, net of unamortized discount of 302,892 and 291,691, respectively
      		                                         23,485,173             
        stockholders' (deficit) equity:
      		                                                      
        total stockholders' (deficit) equity
      		                                         -138,608             
        total liabilities and stockholders' (deficit) equity
      		                                         65,328,725             
        revenue
      		                                                      
        rental revenue
      		                                         2,049,196             
        other income
      		                                         12,471             
        total revenue
      		                                         2,061,667             
        expenses
      		                                                      
        acquisition fees – related party
      		                                         627,000             
        general and administrative
      		                                         505,141             
        management fees – related party
      		                                         360,000             
        depreciation expense
      		                                         659,671             
        interest expense
      		                                         1,519,102             
        total expenses
      		                                         3,670,914             
        net income
      		                                         -1,609,247             
        net income per share
      		                                         -6.44             
        weighted-average shares outstanding – basic and diluted
      		                                         250,000             
        deferred rent receivable and other assets
      		                                          1,226            
        liabilities and shareholders’ equity
      		                                                      
        convertible debenture, due to majority shareholder
      		                                          9,991,940 5,446,102 5,446,102          
        notes payable to majority shareholder
      		                                          388,195 388,195 388,195          
        notes payable related to acquisitions
      		                                          23,880,796 16,592,671  16,760,000         
        shareholders' equity:
      		                                                      
        total shareholders' equity
      		                                          715,772 1,277,465 1,473,792 1,874,069 2,221,309        
        total liabilities and shareholders' equity
      		                                          35,872,802 24,349,378 24,523,248 24,746,893 22,244,759        
        prepaid expense and other assets
      		                                           25,019           
        notes payable
      		                                            16,681,030          
        prepaid expense
      		                                              19,307  3,632      
        convertible debenture, due to shareholder
      		                                             5,446,102         
        notes payable to shareholder
      		                                             38,195         
        accrued interest and other
      		                                              176,153        
        note payable to shareholder
      		                                              38,195 7,776,680       
        note payable
      		                                              15,060,000        
        shareholders' equity
      		                                                      
        liabilities
      		                                                      
        accrued liabilities
      		                                               42,564 20,989 21,142 19,044 9,000 7,500  
        stockholders’ equity
      		                                                      
        common stock
      		                                                      
        authorized: 100,000,000 shares, par value 0.001,
      		                                                      
        8,000,000 share issued and outstanding
      		                                               8,000       
        current assets
      		                                                      
        total current assets
      		                                                7,047 3,466 3,519 11,193 12,313 47,189 
        current liabilities
      		                                                      
        total current liabilities
      		                                                44,304 27,036 19,424 9,380 7,880 380 
        common stock authorized: 200,000,000 shares, par value 0.001, 8,000,000 share issued and outstanding
      		                                                      
        deficit accumulated during the development stage
      		                                                -117,257 -103,570 -95,905 -78,187 -50,567  
        common stock authorized: 200,000,000 shares, par value 0.001 8,000,000 and 5,500,000 shares issued and outstanding as of august 31, 2013 and 2012, respectively
      		                                                  8,000    
        common stock authorized: 200,000,000 shares, par value 0.001 8,000,000 and 5,500,000 share issued and outstanding, respectively
      		                                                   8,000   
        prepaid expenses
      		                                                      
        common stock authorized: 200,000,000 shares, par value 0.001 5,500,000 share issued and outstanding
      		                                                    5,500 5,500 
        deficit accumulated during the exploration stage
      		                                                     -8,191 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-11-30 2014-05-31 2013-11-30 2013-02-28 2012-11-30 2012-08-31 2012-05-31 
                                                           
          operating activities
        		                                                   
          net income
        		1,654,000 -5,058,000 585,000 3,737,000 2,939,000 3,391,000 -1,952,000 2,314,000 551,000 4,833,000 14,177,000 2,173,000 1,848,000 10,029,000 3,833,000 4,286,000 5,487,000 5,368,000 4,164,000 3,323,000 2,592,000 -9,580,000 1,672,000 2,817,000 2,775,000 2,308,000 2,462,000 2,043,000 9,504,000 1,772,000 1,384,000 1,901,000            -188,547     -27,620   
          adjustments to reconcile net income to net cash from operating activities:
        		                                                   
          depreciation expense
        		11,087,000 11,213,000 11,307,000 10,307,000 10,194,000 9,993,000 10,127,000 10,113,000 10,204,000 10,100,000 10,468,000 10,494,000 10,580,000 10,128,000 9,898,000 9,402,000 9,046,000 8,639,000 8,292,000 7,848,000 7,364,000 6,954,000 6,593,000 5,836,000 5,585,000 5,006,000 4,608,000 3,867,000 3,679,000 3,614,000 3,445,000 2,906,000 2,556,692 2,175,668 1,850,587 1,346,053 806,383 585,449 544,002 398,830 213,180 153,148 141,007 152,336 149,720       
          amortization of acquired lease intangible assets
        		3,412,000 3,536,000 3,759,000 3,287,000 3,312,000 3,545,000 3,766,000 3,863,000 3,973,000 4,039,000 4,306,000 4,373,000 4,491,000 4,265,000 4,116,000 3,755,000 3,585,000 3,281,000 3,113,000 2,984,000 2,754,000 2,544,000 2,348,000 1,921,000 1,812,000 1,500,000 1,255,000 1,002,000 980,000 954,000 926,000 765,000 745,605 523,487 459,308 343,600                
          amortization of above market leases
        		146,000 113,000 -60,000 452,000 389,000 282,000 249,000 251,000 240,000 234,000 287,000 291,000 292,000 221,000 315,000 199,000 202,000 173,000 85,000 60,000 32,000 69,000 156,000 247,000 247,000 229,000 186,000 219,000                        
          amortization of debt issuance costs and other
        		807,000 554,000 559,000 559,000 559,000 559,000 563,000 562,000 581,000 593,000 601,000 601,000 601,000 571,000 514,000 515,000 514,000 538,000 505,000 425,000 420,000 396,000 319,000 315,000                            
          stock-based compensation expense
        		1,229,000 1,207,000 1,728,000 151,000 1,276,000 1,274,000 1,319,000 1,233,000 1,222,000 1,185,000 1,147,000 688,000 1,066,000 1,039,000 1,289,000 1,287,000 1,242,000 1,241,000 1,612,000 1,715,000 1,928,000 1,572,000 897,000 922,000 843,000 868,000 854,000 771,000 693,000 741,000 1,055,000 182,000 315,276 340,287 720,827 419,610                
          gain on sale of investment properties
        		   -1,358,000     0 -2,289,000                                          
          equity loss from unconsolidated joint venture
        		11,000 32,000 51,000 40,000                                                
          other
        		-53,000 24,000 45,000 25,000 7,000 -73,000 33,000 169,000 148,000 164,000   -47,000 23,000 16,000 29,000 24,000 16,000 12,000 10,000 -61,000 -1,000 20,000 26,000 23,000 12,000 37,000 33,000                        
          changes in operating assets and liabilities:
        		                                                   
          tenant receivables
        		425,000 -120,000 278,000 -680,000 698,000 -49,000 -1,152,000 -981,000 -87,000 -146,000 21,000 638,000 -1,658,000 -1,193,000 288,000 -407,000 -1,227,000 -240,000 799,000 11,000 870,000 -914,000 -807,000 -751,000 -910,000 -202,000 -376,000 -654,000 -1,161,000 -405,000 -86,000 -549,000 -87,694 -82,257 -187,374 -134,675 -35,066   -261,955            
          deferred assets
        		-1,046,000 -558,000 -479,000 -57,000 -905,000 257,000 -402,000 -863,000 -385,000 -747,000 -920,000 -811,000 -949,000 -1,076,000 -1,017,000 -1,297,000 -1,148,000 -1,372,000 -1,374,000 -1,404,000 -1,345,000 -1,495,000 -1,292,000 -1,629,000 -1,205,000 -1,476,000 -1,473,000 -1,006,000 -1,214,000 -1,962,000 -1,457,000 -1,178,000 -1,069,043 -1,056,484 -779,862 -382,611 -458,918 -90,905 211,003 -342,422            
          other assets and liabilities
        		-1,597,000 229,000 928,000 -2,987,000 3,022,000 -739,000 742,000 -1,033,000 1,329,000 -563,000 -14,000 -210,000 1,396,000 -1,133,000 855,000 -532,000 1,391,000 -1,384,000 -546,000 551,000                                
          accounts payable and accrued expenses
        		-2,788,000 286,000 3,570,000 -1,254,000 2,830,000 425,000 1,785,000 -2,057,000 -1,168,000 -516,000 884,000 -1,223,000 503,000 1,939,000 2,651,000 -1,030,000 -1,032,000 2,094,000 1,149,000 -287,000 393,000 -2,451,000 1,569,000 2,051,000 -54,000 933,000 612,000 -634,000 85,000 180,000 -580,000 1,834,000 -267,426 228,257 35,576 1,358,593      156,289 24,866 -225,403        
          security deposits
        		65,000 105,000 33,000 50,000 102,000 -751,000 -403,000 688,000 -225,000 -300,000 -475,000 -773,000 57,000 100,000 688,000 76,000 -60,000 215,000 18,000 27,000                1,380,252 121,999 278,094 0 319,499            
          net cash from operating activities
        		13,352,000 17,566,000 22,139,000 12,272,000 20,523,000 16,302,000 18,928,000 14,293,000 18,125,000 16,666,000 17,878,000 15,771,000 18,308,000 18,314,000 23,483,000 16,436,000 17,283,000 18,608,000 17,789,000 15,287,000 16,131,000 -5,479,000 11,608,000 12,260,000 9,746,000 10,017,000 10,516,000 6,148,000 5,734,000 4,177,000 5,628,000 9,295,000 4,324,847 3,463,870 2,994,847 819,436 -663,366 -1,854,974 910,821 -1,115,647 -128,636 -69,364 128,626 -139,427 130,465 -5,117 -53 -2,072 -26,120 -15,076 -19,800 
          capital expenditures
        		0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
          free cash flows
        		13,352,000 17,566,000 22,139,000 12,272,000 20,523,000 16,302,000 18,928,000 14,293,000 18,125,000 16,666,000 17,878,000 15,771,000 18,308,000 18,314,000 23,483,000 16,436,000 17,283,000 18,608,000 17,789,000 15,287,000 16,131,000 -5,479,000 11,608,000 12,260,000 9,746,000 10,017,000 10,516,000 6,148,000 5,734,000 4,177,000 5,628,000 9,295,000 4,324,847 3,463,870 2,994,847 819,436 -663,366 -1,854,974 910,821 -1,115,647 -128,636 -69,364 128,626 -139,427 130,465 -5,117 -53 -2,072 -26,120 -15,076 -19,800 
          investing activities
        		                                                   
          purchase of land, buildings, and other tangible and intangible assets and liabilities
        		 0 -38,490,000 -31,978,000 -50,395,000    0 0   -335,000 -50,675,000 -75,449,000 -24,468,000 -26,512,000 -50,198,000 -72,197,000 -43,348,000 -80,862,000 -60,756,000 -7,600,000 -68,457,000 -73,545,000 -65,968,000 -94,631,000 -20,841,000 -46,986,000 -8,977,000 -59,309,000 -65,565,000 -38,684,539 -65,060,983 -40,407,660 -108,066,818                
          net proceeds from sale of investment properties
        		 3,584,000 1,328,000 7,783,000 38,138,000 11,693,000   990,000 9,526,000                                          
          investment in unconsolidated joint venture
        		-7,165,000                                                   
          distribution of capital from unconsolidated joint venture
        		33,000 39,000 25,000 33,000                                                
          escrow deposits for purchase of properties
        		 0 476,000 -186,000 962,000 -752,000      -153,000 400,000 492,000 490,000 -1,284,000 781,000 -225,000 720,000 300,000 -520,000 200,000 600,000 -100,000 -475,000 725,000 -150,000 -1,472,000 948,000 -476,000 500,000 -798,000 -292,000 -309,448 1,557,772 -1,308,324 -290,000 50,000 -50,000 394,310      -7,775,082      
          advances made to related parties
        		-15,000 94,000 -41,000 -150,000  6,000 -47,000 -170,000  102,000 -70,000 -121,000  0 114,000 -288,000                                    
          capital expenditures on existing real estate investments
        		-2,145,000 -3,284,000 -1,965,000 -2,611,000 -3,473,000 -4,766,000 -3,202,000 -2,004,000 -3,826,000 -3,445,000 -1,524,000 -809,000 -1,611,000 -2,154,000 -953,000 -556,000 -7,785,000 -336,000 -887,000 -397,000 -696,000 -75,000 -130,000 -211,000 -1,487,000 -144,000 -184,000 -9,000                        
          leasing commissions
        		-550,000 -1,136,000 -558,000 -115,000 -2,803,000 -390,000 -2,003,000 -542,000 -374,000 -519,000                                          
          net cash from investing activities
        		-9,842,000 -703,000 -39,225,000 -27,224,000 -19,523,000 -25,488,000 1,785,000 -2,716,000 -3,114,000 5,664,000 61,974,000 3,092,000 -1,410,000 -33,448,000 -75,798,000 -26,596,000 -27,925,000 -50,769,000 -72,399,000 -43,572,000 -82,060,000 -65,653,000 -7,196,000 -68,763,000 -75,523,000 -65,200,000 -94,819,000 -22,655,000 -15,187,000 -10,860,000 -59,321,000 -66,250,000 -39,147,426 -65,441,619 -38,814,553 -109,249,402 -82,022,402 -30,694,316 -67,540 -37,573,329 -20,658,635 -11,674,355   -2,506,697 -7,775,082      
          financing activities
        		                                                   
          escrow deposits required by third party lenders
        		   -18,000 21,000 -17,000 312,000 -64,000 8,198,000 -136,000 -263,000 -639,000 -573,000 -444,000 -501,000 -456,000 -768,000 -214,000 -1,088,000 -646,000 -505,000 -649,000 -313,000 -72,000 -77,000 -72,000 -72,000 -72,000 -72,000 -72,000 -72,000 -72,000 -48,512 -8,508 -8,485 -8,495 -18,541 -8,474 -5,643 -829,519            
          repayment of notes payable
        		-57,000 -13,004,000 -104,000 -160,000 -103,000 -154,000 -11,057,000 -230,000 -298,000 -336,000 -284,000 -344,000 -285,000 -321,000 -270,000 -282,000 -272,000 -7,285,000 -256,000 -190,000 -186,000 -120,000                              
          proceeds from credit facility
        		17,100,000 20,900,000 50,500,000 44,000,000 61,000,000 44,300,000 24,500,000 14,000,000 45,000,000 13,500,000 12,000,000 12,600,000 11,500,000 34,600,000 78,400,000 14,100,000 33,900,000 54,600,000 83,000,000 50,100,000 80,000,000 69,700,000 7,000,000 81,700,000 79,800,000 60,650,000 97,600,000 6,200,000                        
          repayment of credit facility
        		-8,275,000 -11,800,000 -15,000,000 -13,500,000 -44,200,000 -29,500,000 -18,100,000 -7,800,000 -21,000,000 -21,243,000 -79,357,000 -14,800,000 -10,500,000 0   -17,000,000 0 -55,400,000 -151,800,000 -13,000,000 -30,700,000 -17,250,000 -3,600,000 -95,675,000 -12,900,000                          
          payment of debt issuance costs
        		-17,000            0 -3,208,000   0 0 -6,103,000 -74,000 -28,000 -1,138,000                              
          dividends paid to common stockholders, and op unit and ltip unit holders
        		-10,939,000 -10,890,000 -15,234,000 -15,269,000 -15,109,000 -14,913,000 -14,900,000 -14,946,000 -14,818,000 -14,820,000 -14,688,000 -14,699,000 -14,641,000 -14,643,000 -14,610,000 -14,526,000 -13,961,000 -13,964,000 -13,260,000 -11,315,000 -10,356,000 -9,913,000 -9,644,000 -10,031,000 -8,004,000 -7,700,000 -7,686,000 -5,781,000 -4,889,000 -4,787,000                      
          dividends paid to preferred stockholders
        		-2,251,000 -1,455,000 -1,456,000 -1,455,000 -1,456,000 -1,455,000 -1,456,000 -1,455,000 -1,456,000 -1,455,000 -1,456,000 -1,455,000 -1,456,000 -1,455,000 -1,456,000 -1,455,000 -1,456,000 -1,455,000 -1,456,000 -1,455,000 -1,456,000 -1,455,000 -1,456,000 -1,455,000 -1,457,000 -1,454,000 -1,456,000 -1,455,000 -1,455,000 -1,455,000 -1,456,000 -1,455,000                    
          net cash from financing activities
        		-4,439,000 -16,249,000 18,724,000 13,598,000 153,000 9,157,000 -20,701,000 -10,495,000 -15,899,000 -24,503,000 -84,048,000 -19,337,000 -16,038,000 14,529,000 58,325,000 5,591,000 11,532,000 31,660,000 55,580,000 28,932,000 69,420,000 65,057,000 -7,951,000 66,194,000 67,136,000 55,137,000 86,867,000 14,972,000 10,474,000 4,318,000 52,479,000 57,242,000 33,155,209 56,720,453 39,496,904 97,115,434 21,008,907 111,322,478 1,224,242 30,011,987 29,883,558 11,702,876 -150,309 207,130 2,545,823 7,776,680  0 25,000   
          net decrease in cash and cash equivalents and restricted cash
        		-929,000           -474,000                  -2,365,000                      
          cash and cash equivalents and restricted cash—beginning of period
        		11,890,000 0 0 8,942,000 0 0 0 6,724,000 0 0 0 14,455,000 0 0 0 12,759,000 0 0 0 10,753,000  0 0 7,185,000 0 0 0 4,843,000 0 0 0 7,114,000                    
          cash and cash equivalents and restricted cash—end of period
        		10,961,000 614,000 1,638,000 7,588,000 1,153,000 -29,000 12,000 7,806,000 -888,000 -2,173,000 -4,196,000 13,981,000 860,000 -605,000 6,010,000 8,190,000 890,000 -501,000 970,000 11,400,000  -6,075,000 -3,539,000 16,876,000 1,359,000 -46,000 2,564,000 3,308,000 1,021,000 -2,365,000 -1,214,000 7,401,000                    
          supplemental cash flow information:
        		                                                   
          cash payments for interest
        		6,533,000 7,862,000 7,758,000 6,568,000 7,047,000 6,942,000 6,176,000 6,407,000 6,859,000 7,004,000 8,147,000 8,139,000 6,367,000 6,206,000 4,788,000 4,258,000 4,400,000 4,125,000 4,580,000 4,602,000 4,568,000 4,423,000 4,093,000 3,823,000 4,595,000 4,166,000 3,807,000 3,714,000 3,971,000 3,514,000 3,347,000 2,245,000 1,817,792 1,448,374 1,649,766 830,068 402,959 2,661,522 697,336 337,609 203,774 270,808 142,425 548,150        
          noncash financing and investing activities:
        		                                                   
          accrued dividends payable
        		12,708,000 66,000 -4,612,000 16,597,000 -14,000 254,000 124,000 16,156,000 79,000 7,000 194,000 15,854,000 44,000 -149,000 103,000 15,823,000 359,000 58,000 769,000 14,482,000 627,000 562,000   1,621,000 389,000   986,000 169,000 116,000 5,710,000 870,963 1,066,101 49,119 3,651,817 11,251               
          interest rate swap agreements fair value change recognized in other comprehensive income
        		-1,116,000  -13,117,000 4,900,000 16,670,000 -12,705,000 6,707,000 -4,160,000 5,844,000 2,520,000   2,209,000 -20,356,000 -5,770,000 -17,393,000                                    
          ltip units and op units redeemed for common stock
        		                 168,000     8,585,000 6,890,000  54,000 0 576,000                        
          accrued capital expenditures and leasing commissions included in accounts payable and accrued expenses
        		889,000 -647,000 515,000 1,769,000 470,000 514,000 -504,000 1,946,000                                            
          recognition of lease liability related to right of use asset
        		 0 2,429,000 3,851,000     0 0                                          
          capitalized preacquisition and other costs charged to expense
        		 16,000   149,000 11,000 48,000 34,000 22,000 79,000 61,000 15,000 128,000 154,000 37,000 153,000                                    
          reserve for uncollectible accounts
        		    0 0                                              
          loss on sale of investment properties
        		 -294,000    -1,823,000                                              
          impairment of investment property
        		                                                   
          net proceeds received from common equity offerings
        		    0        -83,000 0 1,769,000 8,210,000 11,089,000 -22,000 50,143,000 144,312,000 14,951,000 24,532,000   92,699,000 17,148,000 707,000 78,944,000 34,098,000    375                   
          net increase in cash and cash equivalents and restricted cash
        		 614,000 1,638,000 -1,354,000 1,153,000 -29,000 12,000 1,082,000 -888,000 -2,173,000   860,000 -605,000 6,010,000 -4,569,000 890,000 -501,000 970,000 647,000 3,491,000 -6,075,000 -3,539,000 9,691,000 1,359,000 -46,000 2,564,000 -1,535,000                        
          interest rate swap agreements fair value change recognized in other comprehensive loss
        		           7,264,000      -1,838,000 -804,000 -3,631,000 -1,432,000 -2,003,000 1,022,000 13,958,000 -3,922,000 1,303,000 3,550,000 2,022,000                        
          ltip units redeemed for common stock
        		  0 67,000  104,000 4,000 205,000                                            
          loss on extinguishment of debt
        		                                                   
          ​
        		                                                   
          advances (made to) repayments received from related parties
        		                                                   
          payment received on loan made to a tenant
        		            0                                       
          payment for cmbs loan defeasance
        		                                                   
          op units and ltip units redeemed for common stock
        		        0 0 305,000 122,000 0 0 0 682,000     2,636,000                               
          loan assumed in connection with a facility acquisition
        		            0                                       
          op units issued for a property acquisition
        		        0 0                                          
          write off of unamortized debt issuance costs from loan defeasance
        		                                                   
          proceeds from sale of an investment property held in escrow
        		         0                                          
          gain on sale of investment property
        		           -485,000 0                                       
          net proceeds from sale of investment property
        		           4,175,000 0                                       
          repayments received from advances (made to) related parties
        		                                                   
          payment of debt issue costs
        		        0                                           
          accrued capital expenditures included in accounts payable and accrued expenses
        		         -2,199,000 2,134,000 778,000 172,000 -504,000 -144,000 1,841,000 311,000                                   
          accrued management fee due to related party
        		                                                   
          internalization - cash paid for acquisition of former advisor, net of cash acquired of 559
        		                    0                               
          proceeds from notes payable
        		                                                   
          accrued common stock offering costs
        		                  -198,000 220,000 -89,000 99,000   247,000 -362,000 194,000 190,000                        
          capitalized preacquisition costs charged to expense
        		                45,000 39,000 60,000 24,000 -36,000 32,000 128,000 7,000 69,000                           
          noncash lease expense
        		                                                   
          reserve for uncollectible receivables
        		                283,000 0    100,000                              
          accrued management fees due to related party
        		                    0 -2,022,000 20,000 275,000 105,000 38,000 249,000 192,000 38,000 10,000 14,000 17,000 259,904 175,431 1,227 6,438 -306,438 267,147 -60,000 90,000 90,000 90,000 90,000 90,000        
          loans (made to) repayments received from related parties
        		                112,000                                   
          cmbs loan assumed in connection with a facility acquisition
        		                    0 0                              
          op units issued for property acquisitions
        		                                                   
          initial recognition of lease liability related to right of use asset
        		                        0 0 797,000 2,346,000                        
          loans to related parties
        		                                                   
          loan repayments (made to) received from related parties
        		                   -127,000                                
          payment of accrued common stock offering costs
        		                       -269,000                            
          reserve and write off of uncollectible receivables
        		                                                   
          other assets
        		                    75,000 -439,000 89,000 28,000 44,000 -191,000 5,000 32,000 86,000 -223,000 11,000 86,000 -122,110                   
          security deposits and other
        		                    909,000 -244,000 -731,000 195,000 -11,000 481,000 1,759,000 -30,000 224,000 -1,124,000 140,000 2,784,000 -78,553 -238,697                  
          loan repayments from (made to) related parties
        		                                                   
          preacquisition costs
        		                                                   
          proceeds from note payable
        		                    0                               
          redemption of ltip units
        		                            0 0 -105,000 -158,000                    
          cash and cash equivalents and restricted cash—beginning of year
        		                                                   
          cash and cash equivalents and restricted cash—end of year
        		                                                   
          op units issued primarily for property acquisition
        		                                                   
          loan repayments from related parties
        		                                                   
          op units issued for property acquisition
        		                         0 0 506,000                        
          loan repayments received from (made to) related party
        		                       5,000                            
          repayment of note payable
        		                       -35,000  -33,000                          
          payments of debt issuance costs
        		                       -44,000                            
          accrued dividend payable
        		                       10,949,000    8,985,000                        
          advisory expense settled in op units
        		                                154,503                   
          net proceeds received from preferred stock offering
        		                                -187,720                   
          repayment of note payable from related party
        		                                0 0                  
          loans repaid to related party
        		                                                   
          op units issued primarily for property acquisitions
        		                                                   
          reclassification of common stock offering costs to additional paid-in capital
        		                            271,000    -499                   
          reclassification of preferred stock offering costs to preferred stock balance
        		                                191                   
          amortization of deferred financing costs and other
        		                         349,000 338,000 313,000 313,000                       
          payments of deferred financing costs
        		                         -502,000 -393,000 -29,000  -1,627,000 -370,000 -753,000 -122,308 -515,668 -1,507,861 -769,163 -946,160 0 0 -1,090,079            
          accrued preacquisition costs for purchase of properties and tenant improvements
        		                         705,000                          
          construction-in-process completed and transferred to real estate investments
        		                                                   
          loan repayments made to related parties
        		                           -122,000                        
          pre-acquisition costs for purchase of properties
        		                           -211,000 -221,000 139,000 -128,000 246,000 -153,459 -69,232 -5,049 125,740                
          borrowings repaid to related parties
        		                               -18,000                    
          repayment of note payable from third party
        		                           -35,000                        
          repayment of credit facility borrowings
        		                           -62,800,000                        
          accrued pre-acquisition costs for purchase of properties and construction in process
        		                               271,000                    
          amortization of above (below) market leases
        		                              181,000 113,000 115,030 25,016 -2,846 -8,200                
          capitalized acquisition costs charged to expense
        		                                                   
          loans repayments (made to) from related party
        		                                                   
          payments for tenant improvements
        		                            -521,000 -1,577,000                      
          repayment of convertible debenture, due to related party
        		                                                   
          proceeds received from notes payable from acquisitions
        		                                                   
          repayment of notes payable from acquisitions
        		                                                   
          proceeds received from note payable from related party
        		                                                   
          proceeds from revolving credit facility
        		                            43,200,000 12,950,000 65,700,000 64,250,000 38,800,000 -18,400,000 15,600,000 101,200,000                
          repayment of revolving credit facility borrowings
        		                                                   
          conversion of convertible debenture due to majority stockholder to common stock
        		                                                   
          tenant improvements completed and transferred to real estate investments
        		                                                   
          capitalized pre-acquisition costs charged to expense
        		                             86,000                      
          (loans to) repayments from related parties
        		                             31,000                      
          borrowings from related parties
        		                                                   
          repayment of revolving credit facility
        		                             -3,900,000                      
          interest rate swap fair value change recognized in other comprehensive loss
        		                                                   
          accrued pre-acquisition costs for purchase of properties and tenant improvements
        		                             -873,000                      
          op units issued for noncash transaction
        		                             0   10,300,000                   
          accrued preferred stock offering costs
        		                                                   
          amortization of deferred financing costs
        		                              553,000 430,000 383,786 340,637 340,905 158,672    90,241 36,685 30,257 29,796 29,797 29,497       
          net proceeds received from follow-on offering
        		                                                   
          accrued deferred asset costs
        		                                                   
          accrued deferred public offering costs
        		                                                   
          reclassification of deferred follow-on offering costs to additional paid-in capital
        		                                                   
          capitalized deal costs charged to expense
        		                               4,000   2,300 3,150                
          payments for construction in process
        		                               -133,000                    
          dividends paid to common stockholders, and op and ltip unit holders
        		                               -4,552,000                    
          net increase in cash and cash equivalents
        		                               287,000 -1,667,370    -61,676,861 78,773,188 2,067,523 -8,676,989 9,096,287 -40,843 -27,683 67,703        
          net loss
        		                                1,248,172 605,536 600,594 -2,541,302 -1,929,862 -1,982,826 -494,199 -1,946,563 -790,480 -497,793   -283,340       
          adjustments to reconcile net loss to net cash from operating activities:
        		                                                   
          restricted cash
        		                                151,705 376,832 -391,393 -1,130,144 -119,890 -118,690 0 -319,499            
          loans repayments from (made to) related party
        		                                -17,428 -1,956                  
          change in restricted cash
        		                                -117,023 -125,778 -125,778 297,579 -15,678 290,492 300,253 -510,705            
          loans (repaid to) from related party
        		                                -8,851   -450                
          (repayment of) proceeds from convertible debenture, due to related party
        		                                                   
          proceeds from notes payable from acquisitions
        		                                     0 0 41,320,900            
          proceeds from note payable from related party
        		                                      0 450,000            
          cash and cash equivalents—beginning of period
        		                                -131 0 0 19,671,131 0 0 0 9,184,270 -212,596 0 0 301,402        
          cash and cash equivalents—end of period
        		                                -1,667,501 -5,257,296 3,677,198 8,356,599 -61,676,861 78,773,188 2,067,523 507,281 8,883,691 -40,843 -27,683 369,105        
          payments on notes payable from acquisitions
        		                                     -14,600,986 -92,831 -9,317,351            
          dividends paid to stockholders
        		                                 -3,607,727 -3,603,484 -3,604,037 -3,592,786 0 -121,551 -164,152            
          accrued capitalized offering costs
        		                                                   
          loans from related party
        		                                       152,893            
          payments of deferred initial public offering costs
        		                                                   
          net decrease in cash and cash equivalents
        		                                  3,677,198 -11,314,532                
          accrued deferred initial public offering costs
        		                                                   
          accrued capitalized deal costs
        		                                                   
          adjustments to reconcile net loss to net cash provided by (used in) operating activities:
        		                                                   
          prepaid assets
        		                                       -27,925            
          loans to related party
        		                                     40 -17,540 -21,500 -63,513 -65,683          
          conversion of convertible debenture due to majority stockholder to shares of common stock
        		                                      0 15,000,000            
          cash paid for pre-acquisition costs
        		                                                   
          acquisition of land, buildings, and other tangible and intangible assets and liabilities
        		                                                   
          net proceeds received from initial public offering
        		                                    -70,351               
          loan (repayments to) received from related parties
        		                                                   
          proceeds from convertible debenture, due to related party
        		                                                   
          repayments of convertible debenture, due to related party
        		                                                   
          proceeds from notes payable to related parties
        		                                    1,500,000               
          repayments of notes payable from related parties
        		                                                   
          proceeds received from revolving credit facility
        		                                                   
          proceeds from notes payable related to acquisitions
        		                                                   
          payments on notes payable related to acquisitions
        		                                                   
          conversion of convertible debenture due to related party to shares of common stock
        		                                                   
          reclassification of deferred initial public offering costs to additional paid-in capital
        		                                    0               
          amortization of debt discount
        		                                     62,604              
          ltip unit compensation expense
        		                                                   
          accrued expenses
        		                                     -1,509,305 357,531 884,147     130,306       
          purchase of buildings and improvements
        		                                     -30,744,356 0 -37,946,139            
          loans received from related parties
        		                                                   
          repayment of notes payable from related parties
        		                                                   
          conversion of convertible debenture due to zh usa, llc to shares of common stock
        		                                                   
          loans from related parties
        		                                                   
          proceeds from note payable to majority stockholder
        		                                                   
          accounts receivable
        		                                           2,390 -2,793       
          prepaid expense
        		                                            19,307       
          proceeds from convertible debenture to majority stockholder
        		                                                   
          deferred rent receivable and other assets
        		                                                   
          purchase of land, buildings and improvements
        		                                                   
          proceeds from convertible debenture, due to majority shareholder
        		                                                   
          proceeds from notes payable to majority shareholder
        		                                         0 0 350,000        
          payments on notes payable to majority shareholder
        		                                                   
          principal payments on notes payable related to acquisitions
        		                                         -89,375          
          dividends paid to common shareholders
        		                                         -42,600 -63,900 -63,900        
          payment of deferred financing costs
        		                                            -21,577       
          noncash financing activity:
        		                                                   
          notes payable to majority shareholder converted to equity
        		                                                   
          prepaid expense and other assets
        		                                                   
          principal payments on notes payable
        		                                           -78,970        
          2015
        		                                                   
          2016
        		                                                   
          2017
        		                                                   
          total payments
        		                                                   
          due to related party
        		                                            87,768       
          purchase of building and improvements
        		                                            -2,506,697       
          proceeds from convertible debenture from shareholder
        		                                            910,000       
          proceeds from notes payable related to acquisition
        		                                            1,700,000       
          dividends paid
        		                                            -42,600       
          net increase in cash
        		                                            169,591  -53 -2,072 -1,120  -19,800 
          cash and cash equivalents at beginning of period
        		                                            162,985       
          cash and cash equivalents at end of period
        		                                            332,576       
          supplemental disclosure of cash flow information
        		                                                   
          interest paid
        		                                            206,536       
          supplemental disclosure of non-cash financing activity
        		                                                   
          dividends payable
        		                                            21,300       
          accrued interest and other
        		                                                   
          due to related parties
        		                                              5,514     
          escrow deposits used for purchase of properties
        		                                                   
          proceeds from issuance of common shares
        		                                                   
          proceeds from convertible debenture due to related party
        		                                                   
          proceeds from note payable to shareholder
        		                                                   
          payment on note payable to shareholder
        		                                                   
          supplemental disclosures of cash flow information
        		                                                   
          income taxes paid
        		                                                   
          supplemental disclosures of non-cash information
        		                                                   
          conversion of debt to common shares
        		                                                   
          net loss for the period
        		                                             -28,257      
          adjustments to reconcile net loss to net
        		                                                   
          cash from operating activities:
        		                                                   
          accounts payable – related party
        		                                             -380      
          accrued liabilities
        		                                             23,520 2,098 1,500 1,500 1,500  
          proceeds from issuance of common stock
        		                                               0 25,000   
          proceeds from related party debt
        		                                             7,776,680      
          net change in cash
        		                                             -3,519      
          cash, beginning of period
        		                                             3,519 3,519 0 12,313 0 0 
          cash, end of period
        		                                              3,466 -2,072 11,193 -15,076 -19,800 
          supplemental disclosures
        		                                                   
          net income for the period
        		                                              -7,665    -25,800 
          adjustments to reconcile net income to net
        		                                                   
          prepaid expenses
        		                                                 0 0 
          exhibit no.
        		                                                   
          3.1*
        		                                                   
          3.2*
        		                                                   
          3.3*
        		                                                   
          3.4*
        		                                                   
          4.1*
        		                                                   
          31.1*
        		                                                   
          31.2*
        		                                                   
          32.1*
        		                                                   
          101.ins **
        		                                                   
          101.sch **
        		                                                   
          101.cal **
        		                                                   
          101.def **
        		                                                   
          101.lab **
        		                                                   
          101.pre **
        		                                                   
          3.1
        		                                                   
          3.2
        		                                                   
          3.3
        		                                                   
          3.4
        		                                                   
          4.1
        		                                                   
          31.1
        		                                                   
          32.1
        		                                                   
          101.ins *
        		                                                   
          101.sch *
        		                                                   
          101.cal *
        		                                                   
          101.def *
        		                                                   
          101.lab *
        		                                                   
          101.pre *
        		                                                   
          deferred income tax asset
        		                                                   
          net operating income carry forward
        		                                                   
          valuation allowance
        		                                                   
          net deferred tax assets
        		                                                   
          revenue
        		                                                   
          total operating expenses
        		                                                   
          net increase/(decrease) in cash
        		                                                   
          income tax benefit computed at statutory rates
        		                                                   
          benefit from income taxes
        		                                                   
          item 2.